Our mission is to research and develop novel cellular therapies for diseases and to accelerate personalized medicine to market.
We are a privately-held biotechnology company located in Huntersville, North Carolina focused on Cancer Immunotherapy.
We collaborate with industry leaders to solve translational research, biospecimen sourcing, & cell manufacturing problems in real-time.
Our expert Providers participate in national clinical trials to advance cancer immunotherapy research and to help bring novel therapies to patients.
Our portfolio of nonclinical cell therapy programs leverages the intrinsic specificity of autologous immune cells to potentially treat solid tumors.
